Application 211298
- Type
- ANDA
- Sponsor
- UMEDICA LABS PVT LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 2.5MG | No | No |
| 002 | TADALAFIL | TADALAFIL | TABLET;ORAL | 5MG | No | No |
| 003 | TADALAFIL | TADALAFIL | TABLET;ORAL | 10MG | No | No |
| 004 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211298-001 | TADALAFIL | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2020-10-23 | |
| A211298-002 | TADALAFIL | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2020-10-23 | |
| A211298-003 | TADALAFIL | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2020-10-23 | |
| A211298-004 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2020-10-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211298-001 | AB1 |
| A211298-002 | AB1 |
| A211298-003 | AB1 |
| A211298-004 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2020-10-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2020-10-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2020-10-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2020-10-23 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2020-10-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2020-10-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2020-10-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2020-10-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2020-10-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2020-10-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2020-10-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2020-10-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-001 | TADALAFIL | 2.5MG | TABLET / ORAL | BX | 2020-10-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-002 | TADALAFIL | 5MG | TABLET / ORAL | BX | 2020-10-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-003 | TADALAFIL | 10MG | TABLET / ORAL | BX | 2020-10-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-004 | TADALAFIL | 20MG | TABLET / ORAL | BX | 2020-10-23 | d8e5a09893c0… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A211298-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A211298-002 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A211298-003 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A211298-004 | AB1 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211298-004 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-002 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-003 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211298-004 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-001 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-002 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-003 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211298-004 | BX | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-001 | BX | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-002 | BX | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-003 | BX | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211298-004 | BX | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-001 | BX | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-002 | BX | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-003 | BX | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211298-004 | BX | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-001 | BX | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-002 | BX | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-003 | BX | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211298-004 | BX | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-001 | BX | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-002 | BX | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-003 | BX | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211298-004 | BX | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-001 | BX | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-002 | BX | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-003 | BX | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211298-004 | BX | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-001 | BX | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-002 | BX | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-003 | BX | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211298-004 | BX | 1 | d8e5a09893c0… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | NorthStar Rx, LLC | a10d464a-6ea7-4e5a-befa-71eceacc5039 | 2026-07-30 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | Umedica Laboratories USA Inc. | 6caf3b55-9bf4-4355-9e25-8bf368943fdd | 2026-04-26 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | NIVAGEN PHARMACEUTICALS, INC. | ca1d46e3-ad9b-48c7-bb7f-63ee678ccf7a | 2025-12-09 | Warnings, Adverse reactions | 211298 ANDA211298 75834-250 75834-247 75834-249 75834-248 |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | e899da81-a28e-4a7e-a0e6-ed6d557c0bcd | 2025-04-08 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 828f0ee1-b9fc-4743-9394-fc086bcf5345 | 2025-04-08 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | Proficient Rx LP | a930511d-110e-4d2e-a4ca-df712f968b2d | 2024-04-01 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | Proficient Rx LP | 78b6659c-3a46-4998-9151-1a53afd83375 | 2024-04-01 | Warnings, Adverse reactions | 211298 ANDA211298 |
| Tadalafil | TADALAFIL | Proficient Rx LP | 7dfb450b-4d39-40e7-b115-9a96023052a0 | 2023-11-01 | Warnings, Adverse reactions | 211298 ANDA211298 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 75834-247 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-247 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-247 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-248 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-248 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-248 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-249 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-249 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-249 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-250 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-250 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |
| 75834-250 | Tadalafil | Tadalafil | NIVAGEN PHARMACEUTICALS, INC. | ANDA | Current |